Related Experiment Videos
[Autoimmune pancreatitis--a surgical disease?]
J Kleeff1, T Welsch, I Esposito
1Abteilung für Allgemein-, Viszeral- und Unfallchirurgie, Chirurgische Klinik, Universität Heidelberg.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|October 7, 2005
Summary
Autoimmune pancreatitis (AIP) is a chronic condition causing pancreatic duct narrowing, often mistaken for cancer. Steroid treatment shows promise for symptom and ductal narrowing relief in AIP patients.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Context:
- Autoimmune pancreatitis (AIP) is a distinct form of chronic pancreatitis.
- Characterized by lymphoplasmocytic infiltration, fibrosis, and ductal stenosis.
- Often misdiagnosed as pancreatic cancer due to imaging findings.
Purpose:
- To summarize current knowledge on autoimmune pancreatitis.
- To present findings from 17 surgical resection cases.
- To highlight the diagnostic and therapeutic challenges of AIP.
Summary:
- AIP involves CD4+ T cells, fibrosis, and acinar atrophy, leading to pancreatic and bile duct narrowing.
- Clinical manifestations include pain, jaundice, pancreatitis, and new-onset diabetes.
- Associated with other autoimmune conditions and marked by elevated IgG4 levels.
- Steroid therapy demonstrates efficacy in symptom and ductal narrowing improvement.
Impact:
- Differentiating AIP from pancreatic neoplasms is crucial for appropriate management.
- Steroids offer a potential treatment modality, distinguishing AIP from other pancreatitis types.
- Further research is needed for improved diagnostics, understanding pathophysiology, and prognosis.